US2010168166A1PendingUtilityA1

Method of Providing An Antihistaminic Effect in a Hepatically Impaired Patient

Individually held — no corporate assignee on recordPriority: May 11, 1992Filed: Jul 1, 2009Published: Jul 1, 2010
Est. expiryMay 11, 2012(expired)· nominal 20-yr term from priority
A61P 37/08A61P 43/00A61P 11/06A61K 31/445
65
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a method of providing an antihistaminic effect in a hepatically impaired patient in need thereof comprising administering to said patient an effective antihistaminic amount of a compound of the formula wherein R 1 is hydrogen or hydroxy; R 2 is hydrogen; or R 1 and R 2 taken together form a second bond between the carbon atoms bearing R 1 and R 2 ; n is an integer of from 1 to 5; R 3 is —COOH or —COOalkyl wherein the alkyl moiety has from 1 to 6 carbon atoms and is straight or branched; each of A and B is hydrogen or hydroxy with the proviso that at least one of A or B is hydrogen; or a pharmaceutically acceptable salt and individual isomers thereof.

Claims

exact text as granted — not AI-modified
1 - 7 . (canceled) 
     
     
         8 . A method of providing an antihistaminic effect in a hepatically impaired patient in need thereof comprising administering to said patient an effective antihistaminic amount of (R)-4-[1-hydroxy-4-[4-hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl-benzeneacetic acid, (S)-4-[1-hydroxy-4-[4-hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl-benzeneacetic acid, or a pharmaceutically acceptable salt thereof.

Join the waitlist — get patent alerts

Track US2010168166A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.